Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 3Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 61Stomach Neoplasms 27Rectal Neoplasms 20Colonic Neoplasms 19Small Cell Lung Carcinoma 12Neoplasm Metastasis 11Pancreatic Neoplasms 10Locally Advanced Rectal Cancer 5Colorectal Cancer Metastatic 5Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Biliary Tract Neoplasms 4Recurrence 3Liver Neoplasms 3Glioblastoma 3Gastrointestinal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Solid Tumors 2Sarcoma 2Lung Neoplasms 2Glioma 2Gallbladder Neoplasms 2Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 2Advanced Colorectal Cancer 2mCRC 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocytopenia 1Second Line Treatment of Gastric Cancer 1

Interventions

Folfox protocol 2Drug Therapy 2Bevacizumab 2camrelizumab 1apatinib 1aldesleukin 1XELOX 1Trastuzumab 1Radiotherapy 1Oxaliplatin 1Leucovorin 1Irinotecan 1Intermittent Pneumatic Compression Devices 1Fluorouracil 1Endoscopy 1Chemoradiotherapy 1Cathartics 1Capecitabine 1Aspirin 1Artesunate 1Anti-Bacterial Agents 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Intestinal Neoplasms × Irinotecan × Clear all
NCT03303495 2017-10-06

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Sun Yat-sen University

Phase 3 Unknown
280 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡